Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash ...

The case centers on the federal 340B program, in which drugmakers provide discounts to eligible healthcare providers that ...

Eli Lilly is taking the HRSA to court after the latter allegedly blocked the pharma's plan on the manner of offering ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

Dr. Ryan Kruis The project will be led by Ryan Kruis, Ph.D., director of grants and research at the MUSC Center for Telehealth, one of two HRSA-designated Telehealth Centers of Excellence. The Center ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...

The aims of the 340B program are important. But, unfortunately, there is little evidence that the program is delivering on ...

BROCKPORT — Oak Orchard Health plans to expand its behavioral health services in Genesee County, thanks to a $600,000 award ...

Dr. Ryan Kruis, director of grants and research for the Telehealth Research Program at the Medical University of South Carolina, has been awarded $1.75 million by HRSA to leverage telehealth to ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...